What we do Symbiotec Pharmalab Ltd manufactures steroid and corticosteroid Active Pharmaceutical Ingredients (APIs) and intermediates, specializing in progesterone with advanced flow chemistry technology. |
Founded in 2,002 |
Market share Global leader in corticosteroid and steroidal-hormone API manufacturing, uniquely positioned as the only Indian continuous progesterone API producer. |
Problem solved Provides high-quality, regulatory-compliant steroid APIs addressing global demand for critical hormone and corticosteroid medications. |
Top clients or who we serve Supplies pharmaceutical companies worldwide; operates in B2B market serving regulated global pharmaceutical firms. |
Key management - |
Our journey and innovations Evolved from lab-scale API manufacture in 1995 to industrial-scale with USFDA, EU-GMP, and Korean approvals; commissioned multiple advanced biotech and fermentation plants. |
Where we operate Primarily India with significant international exports under global regulatory approvals. |
Top products or what we offer Progesterone API, corticosteroid APIs, fermentation-based steroidal intermediates, complex injectables manufacturing. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Predominantly recurring revenue from ongoing API sales to pharmaceutical manufacturers. |
Our industry position Strong global positions with advanced manufacturing capabilities and regulatory approvals supporting leadership in steroid APIs. |
Financial highlights Revenue Rs 869.15 crore, Net Profit Rs 109.88 crore for fiscal year ending 2026. |
Geographical revenue split India contributes approx. Rs 287 crore; international markets approx. Rs 583 crore revenue. |
Order book - |
Whats driving growth Expansion in fermentation and injectable capacity; global demand for steroid APIs; regulatory approvals support exports. |
Our future plans IPO planned to raise Rs 2180 crore for capacity expansion and technological advancements. |
Our green promise - |
Our people and values - |
Key challenges ahead Managing large-scale capacity expansion and maintaining global regulatory compliance ahead of growth. |
Interesting facts Only Indian company with continuous manufacturing for progesterone API using flow chemistry technology. |
Risks and strategy - |
